CDIO: Cardio Diagnostics Holdings, Inc. Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 15.07
Enterprise Value ($M) 14.16
Book Value ($M) 2.96
Book Value / Share 0.14
Price / Book 5.09
NCAV ($M) 1.26
NCAV / Share 0.06
Price / NCAV 11.95

Profitability (mra)
Return on Invested Capital (ROIC) -1.99
Return on Assets (ROA) -0.98
Return on Equity (ROE) -2.45

Liquidity (mrq)
Quick Ratio 3.29
Current Ratio 3.29

Balance Sheet (mrq) ($M)
Current Assets 2.77
Assets 4.46
Liabilities 1.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.02
Operating Income -7.24
Net Income -8.38
Earnings Per Shares Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -5.67
Cash from Investing -0.79
Cash from Financing 3.63

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-02 13G BlackRock Inc. 5.20
06-28 13D/A Philibert Robert 19.10 -25.51
06-28 13D/A Dogan Meeshanthini 20.90 -86.47

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUA
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 35,216 123,008 28.63
2024-04-30 91,711 43,599 210.35
2024-04-29 94,251 46,511 202.64
2024-04-26 92,290 47,012 196.31

(click for more detail)

Similar Companies
CALC – CalciMedica, Inc. CAPR – Capricor Therapeutics, Inc.
CASI – CASI Pharmaceuticals, Inc. CDMO – Avid Bioservices, Inc.
CDTX – Cidara Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io